• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

某些生物标志物作为埃及女性乳腺癌有无转移预测指标的临床效用。

Clinical utility of certain biomarkers as predictors of breast cancer with or without metastasis among Egyptian females.

作者信息

Ahmed Samia A, Hamed Manal A, Omar Omar S

机构信息

Therapeutic Chemistry Department, National Research Centre, El-Bohooth St., Dokki, Cairo, Egypt.

出版信息

Tumour Biol. 2015 Feb;36(2):815-22. doi: 10.1007/s13277-014-2689-z. Epub 2014 Oct 9.

DOI:10.1007/s13277-014-2689-z
PMID:25296733
Abstract

The objective of this study is to explore and correlate the value of certain biomarkers in breast cancer (BC) females with and without metastasis after undergoing the surgical treatment protocol in the National Cancer Institute in Egypt. Thirty females (33-69 years), diagnosed as early breast cancer patients with or without metastasis, and 20 healthy individuals were selected for this study. The biomarkers under investigation were vascular endothelial growth factor (VEGF), C-reactive protein (CRP), interleukin-6 (IL-6), and interleukin-8 (IL-8). The correlation between these markers and the tumor grade was also evaluated. The results revealed a significant increase (p < 0.0001) in VEGF, CRP, IL-6, and IL-8 in breast cancer patients with or without metastasis as compared to the healthy group. Surgical treatment of metastatic BC females showed a significant reduction of those parameters by variable degrees, whereas BC females without metastasis recorded the most inhibition levels. Also, there was positive correlation (p < 0.0001) between those biomarkers and the tumor grades. We also noticed an association between VEGF and IL-8 as well as CRP and IL-6. In conclusion, the selected biomarkers may be beneficial for the prognosis of breast cancer and seem to be a diagnostic tool to differentiate between BC with or without metastasis. The descried surgical treatment protocol succeeded to attenuate the elevated biomarker levels and improve patient survival which deserves more extensive studies.

摘要

本研究的目的是探究并关联埃及国家癌症研究所接受手术治疗方案的有转移和无转移乳腺癌(BC)女性中某些生物标志物的价值。本研究选取了30名女性(33 - 69岁),她们被诊断为有或无转移的早期乳腺癌患者,以及20名健康个体。所研究的生物标志物包括血管内皮生长因子(VEGF)、C反应蛋白(CRP)、白细胞介素-6(IL-6)和白细胞介素-8(IL-8)。还评估了这些标志物与肿瘤分级之间的相关性。结果显示,与健康组相比,有或无转移的乳腺癌患者的VEGF、CRP、IL-6和IL-8均显著升高(p < 0.0001)。转移性BC女性的手术治疗使这些参数在不同程度上显著降低,而无转移的BC女性记录的抑制水平最高。此外,这些生物标志物与肿瘤分级之间存在正相关(p < 0.0001)。我们还注意到VEGF与IL-8以及CRP与IL-6之间存在关联。总之,所选生物标志物可能有助于乳腺癌的预后评估,似乎是区分有转移和无转移BC的诊断工具。所描述的手术治疗方案成功降低了升高的生物标志物水平并提高了患者生存率,这值得更广泛的研究。

相似文献

1
Clinical utility of certain biomarkers as predictors of breast cancer with or without metastasis among Egyptian females.某些生物标志物作为埃及女性乳腺癌有无转移预测指标的临床效用。
Tumour Biol. 2015 Feb;36(2):815-22. doi: 10.1007/s13277-014-2689-z. Epub 2014 Oct 9.
2
Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.术前血清血管内皮生长因子、白细胞介素-6 和 C 反应蛋白水平在结直肠癌中的临床意义。
BMC Cancer. 2010 May 14;10:203. doi: 10.1186/1471-2407-10-203.
3
Plasma TuM2-PK correlates with tumor size, CRP and CA 15-3 in metastatic breast carcinomas; short versus long term follow up study of the Egyptian breast cancer patients.转移性乳腺癌中血浆TuM2-PK与肿瘤大小、CRP及CA 15-3的相关性;埃及乳腺癌患者的短期与长期随访研究
Cancer Biomark. 2017 Aug 23;20(2):123-133. doi: 10.3233/CBM-160482.
4
Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration.巴基斯坦年龄相关性黄斑变性患者基因多态性与血清炎症和血管生成因子水平的关联
Mol Vis. 2015 Aug 29;21:985-99. eCollection 2015.
5
Adipocytes Promote Early Steps of Breast Cancer Cell Dissemination Interleukin-8.脂肪细胞促进乳腺癌细胞扩散的早期步骤 白细胞介素-8。
Front Immunol. 2018 Jul 30;9:1767. doi: 10.3389/fimmu.2018.01767. eCollection 2018.
6
Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.炎症生物标志物与乳腺癌风险:嵌套在 EPIC-Varese 队列中的病例对照研究。
Sci Rep. 2017 Oct 5;7(1):12708. doi: 10.1038/s41598-017-12703-x.
7
Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients.术前血清白细胞介素-6 和 C 反应蛋白水平在乳腺癌患者中的临床意义。
World J Surg Oncol. 2011 Feb 6;9:18. doi: 10.1186/1477-7819-9-18.
8
Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.真核生物起始因子4E(eIF4E)与血管生成:乳腺癌的预后标志物
BMC Cancer. 2006 Sep 30;6:231. doi: 10.1186/1471-2407-6-231.
9
Genetic Effects of Vascular Endothelial Growth Factor A (VEGF-A) and Its Association with Disease Progression in Breast Cancer Population of Saudi Arabia.血管内皮生长因子A(VEGF-A)的遗传效应及其与沙特阿拉伯乳腺癌人群疾病进展的关联
Asian Pac J Cancer Prev. 2020 Jan 1;21(1):139-145. doi: 10.31557/APJCP.2020.21.1.139.
10
Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer.癌细胞衍生的白细胞介素1α有助于乳腺癌中促转移基因的自分泌和旁分泌诱导。
Biochem Biophys Res Commun. 2000 Aug 18;275(1):60-2. doi: 10.1006/bbrc.2000.3241.

引用本文的文献

1
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.监测血清DNA甲基化作为转移性乳腺癌反应和生存的早期独立标志物:TBCRC 005前瞻性生物标志物研究
J Clin Oncol. 2017 Mar;35(7):751-758. doi: 10.1200/JCO.2015.66.2080. Epub 2016 Nov 21.
2
Community-based participatory research to improve life quality and clinical outcomes of patients with breast cancer (DianaWeb in Umbria pilot study).基于社区的参与性研究以改善乳腺癌患者的生活质量和临床结局(翁布里亚地区的DianaWeb试点研究)
BMJ Open. 2016 Jun 1;6(6):e009707. doi: 10.1136/bmjopen-2015-009707.

本文引用的文献

1
N-acetylglucosaminidase, myeloperoxidase and vascular endothelial growth factor serum levels in breast cancer patients.乳腺癌患者血清中N-乙酰氨基葡萄糖苷酶、髓过氧化物酶和血管内皮生长因子水平
Biomed Pharmacother. 2014 Mar;68(2):185-9. doi: 10.1016/j.biopha.2013.10.009. Epub 2013 Nov 8.
2
Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients.黏蛋白 1 及其与卵巢癌患者分级、分期和生存的关系。
BMC Cancer. 2012 Dec 15;12:600. doi: 10.1186/1471-2407-12-600.
3
Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals.
五项血管内皮生长因子(VEGF)多态性与乳腺癌风险:一项涉及 16703 人的荟萃分析。
Cytokine. 2011 Nov;56(2):167-73. doi: 10.1016/j.cyto.2011.06.018. Epub 2011 Jul 27.
4
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.血浆 C 反应蛋白水平升高与乳腺癌预后不良相关:一项队列研究。
Breast Cancer Res. 2011 Jun 3;13(3):R55. doi: 10.1186/bcr2891.
5
Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients.术前血清白细胞介素-6 和 C 反应蛋白水平在乳腺癌患者中的临床意义。
World J Surg Oncol. 2011 Feb 6;9:18. doi: 10.1186/1477-7819-9-18.
6
Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: multivariate analysis of a French multicentre study.血清肿瘤标志物测定对卵巢交界性肿瘤患者管理的影响:法国多中心研究的多变量分析。
Eur J Surg Oncol. 2010 Nov;36(11):1066-72. doi: 10.1016/j.ejso.2010.07.004.
7
Vascular endothelial growth factor in the serum of breast cancer patients.乳腺癌患者血清中的血管内皮生长因子
Bull Exp Biol Med. 2009 Sep;148(3):419-24. doi: 10.1007/s10517-010-0727-4.
8
Immunity, inflammation, and cancer.免疫、炎症与癌症。
Cell. 2010 Mar 19;140(6):883-99. doi: 10.1016/j.cell.2010.01.025.
9
Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer.血管内皮生长因子及其与乳腺癌、卵巢癌和宫颈癌的预后和治疗的关系。
Angiogenesis. 2010 Mar;13(1):43-58. doi: 10.1007/s10456-010-9163-3. Epub 2010 Mar 14.
10
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.CXCR1 阻断在体外和异种移植中选择性靶向人乳腺癌干细胞。
J Clin Invest. 2010 Feb;120(2):485-97. doi: 10.1172/JCI39397. Epub 2010 Jan 4.